Cannabidivarin for HIV‐associated neuropathic pain – A randomized, blinded, controlled clinical trial
Although
cannabidivarin was safe, it did not lead to reduction in neuropathic pain in
HIV‐patients. This may be due to a lack of cannabinoid receptor ...
|
View article...